Deep Brain Stimulation in the Treatment of Tardive Dyskinesia.
antipsychotics
deep brain stimulation
schizophrenia
tardive dyskinesia
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Feb 2023
27 Feb 2023
Historique:
received:
09
11
2022
revised:
15
02
2023
accepted:
21
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Tardive dyskinesia (TD) is a phenomenon observed following the predominantly long-term use of dopamine receptor blockers (antipsychotics) widely used in psychiatry. TD is a group of involuntary, irregular hyperkinetic movements, mainly in the muscles of the face, eyelid, lips, tongue, and cheeks, and less frequently in the limbs, neck, pelvis, and trunk. In some patients, TD takes on an extremely severe form, massively disrupting functioning and, moreover, causing stigmatization and suffering. Deep brain stimulation (DBS), a method used, among others, in Parkinson's disease, is also an effective treatment for TD and often becomes a method of last resort, especially in severe, drug-resistant forms. The group of TD patients who have undergone DBS is still very limited. The procedure is relatively new in TD, so the available reliable clinical studies are few and consist mainly of case reports. Unilateral and bilateral stimulation of two sites has proven efficacy in TD treatment. Most authors describe stimulation of the globus pallidus internus (GPi); less frequent descriptions involve the subthalamic nucleus (STN). In the present paper, we provide up-to-date information on the stimulation of both mentioned brain areas. We also compare the efficacy of the two methods by comparing the two available studies that included the largest groups of patients. Although GPi stimulation is more frequently described in literature, our analysis indicates comparable results (reduction of involuntary movements) with STN DBS.
Identifiants
pubmed: 36902655
pii: jcm12051868
doi: 10.3390/jcm12051868
pmc: PMC10003252
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
J Neurol Sci. 2018 Jun 15;389:67-75
pubmed: 29454493
Eur Neuropsychopharmacol. 2010 Oct;20(10):688-94
pubmed: 20605420
Mov Disord. 2003 Apr;18(4):436-42
pubmed: 12671953
Chin Med J (Engl). 2006 Dec 20;119(24):2069-74
pubmed: 17199958
Mov Disord. 2004 May;19(5):583-5
pubmed: 15133825
Neurosurgery. 2004 Dec;55(6):1361-8; discussion 1368-70
pubmed: 15574217
Arch Neurol. 2011 Feb;68(2):165
pubmed: 20937936
Biol Psychiatry. 2010 Feb 1;67(3):279-82
pubmed: 19875103
Am J Psychiatry. 1998 Sep;155(9):1207-13
pubmed: 9734544
Mov Disord. 2002;17 Suppl 3:S181-7
pubmed: 11948775
Neuroscience. 2008 Mar 18;152(2):558-71
pubmed: 18280046
Neurol Neurochir Pol. 2016 Jul-Aug;50(4):258-61
pubmed: 27375139
Neurology. 2013 Jul 30;81(5):463-9
pubmed: 23897874
Stereotact Funct Neurosurg. 2008;86(1):44-53
pubmed: 17881888
J Neurosurg. 2006 Apr;104(4):488-501
pubmed: 16619651
Neurology. 2005 Jan 25;64(2):344-6
pubmed: 15668437
Stereotact Funct Neurosurg. 1999;72(2-4):225-32
pubmed: 10853082
Schizophr Bull. 2009 Mar;35(2):415-24
pubmed: 18791074
Stereotact Funct Neurosurg. 2010;88(5):304-10
pubmed: 20588082
Mov Disord. 2009 Jan 15;24(1):57-63
pubmed: 18855925
Nat Rev Neurol. 2021 Feb;17(2):75-87
pubmed: 33244188
Arch Neurol. 2005 Aug;62(8):1250-5
pubmed: 15956104
Hong Kong Med J. 2014 Oct;20(5):455-9
pubmed: 25307076
Stereotact Funct Neurosurg. 2007;85(5):235-42
pubmed: 17534136
Neurology. 2006 Jan 10;66(1):142-3
pubmed: 16401868
Mov Disord. 2004 Aug;19(8):969-72
pubmed: 15300668
Mol Psychiatry. 2008 May;13(5):544-56
pubmed: 18180754
J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1713-6
pubmed: 16291900
Chin Med J (Engl). 2016 May 20;129(10):1257-8
pubmed: 27174342
Mov Disord. 2020 Aug;35(8):1369-1378
pubmed: 32246798
Curr Psychiatry Rep. 2011 Aug;13(4):295-304
pubmed: 21519907
Neurotherapeutics. 2014 Jan;11(1):166-76
pubmed: 24310603
Arch Psychiatr Nervenkr (1970). 1983;233(5):371-9
pubmed: 6139995
J Psychiatr Res. 2007 Nov;41(9):801-3
pubmed: 16962613
Neurol Ther. 2021 Jun;10(1):7-30
pubmed: 33140286
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:207-13
pubmed: 23123399
J Neurosurg. 2013 Aug;119(2):301-6
pubmed: 23724986
Focus (Am Psychiatr Publ). 2020 Oct;18(4):493-497
pubmed: 33343262
Arch Gen Psychiatry. 2007 Feb;64(2):170-6
pubmed: 17283284
J Cereb Blood Flow Metab. 2008 Jun;28(6):1127-38
pubmed: 18231115
Can J Psychiatry. 2019 Jun;64(6):388-399
pubmed: 30791698
Acta Neurochir (Wien). 2011 Dec;153(12):2319-27; discussion 2328
pubmed: 21909834
Stereotact Funct Neurosurg. 2009;87(5):322-9
pubmed: 19713732
J Clin Psychiatry. 2012 Nov;73(11):1434-8
pubmed: 23218160
J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):557-9
pubmed: 11254790
Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):9-37
pubmed: 21162693
J Parkinsons Dis. 2020;10(4):1493-1502
pubmed: 32955467
Neurology. 2018 Aug 7;91(6):e543-e550
pubmed: 29970404
Biol Psychiatry. 2004 Oct 1;56(7):522-6
pubmed: 15450789
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1161-3
pubmed: 16024899
Pharmacogenet Genomics. 2008 Apr;18(4):317-23
pubmed: 18334916
Stereotact Funct Neurosurg. 2010;88(2):81-7
pubmed: 20068383
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):710-716
pubmed: 29386253
Parkinsonism Relat Disord. 2007 Dec;13(8):541-4
pubmed: 17236806
Int Rev Neurobiol. 2011;98:231-64
pubmed: 21907090
Parkinsonism Relat Disord. 2017 Aug;41:58-65
pubmed: 28552340
J Neurosci. 2012 Jul 11;32(28):9574-81
pubmed: 22787043
Parkinsonism Relat Disord. 2013 Feb;19(2):141-7
pubmed: 23099106
Neurology. 1985 Jan;35(1):73-7
pubmed: 3966004
Acta Neurochir Suppl. 2007;97(Pt 2):207-14
pubmed: 17691306
Mov Disord. 2010 Dec 15;25(16):2809-17
pubmed: 20939080
Stereotact Funct Neurosurg. 2014;92(4):242-50
pubmed: 25170634
Neurology. 2003 Jan 14;60(1):78-81
pubmed: 12525722
Psychiatry Res. 1991 Nov;40(3):157-66
pubmed: 1685788
Mov Disord. 2010 Jul 30;25(10):1477-81
pubmed: 20629157
Mov Disord. 2008 Oct 15;23(13):1929-31
pubmed: 18785227
Neuropsychopharmacology. 2010 Apr;35(5):1155-64
pubmed: 20072119
J Neurosurg Sci. 2007 Dec;51(4):153-8
pubmed: 18176524
J Neurol. 2014 Aug;261(8):1636-7
pubmed: 24920493
Acta Neurol Scand. 2009 Apr;119(4):269-73
pubmed: 18976318
Int Clin Psychopharmacol. 1986 Apr;1(2):134-44
pubmed: 3571941
Pharmacogenomics. 2008 Sep;9(9):1285-306
pubmed: 18781856
Parkinsonism Relat Disord. 2019 Feb;59:151-154
pubmed: 30522959
Neuropsychopharmacology. 2000 Aug;23(2):170-7
pubmed: 10882843
Brain Stimul. 2017 Sep - Oct;10(5):994-996
pubmed: 28647175
Arch Neurol. 2006 Sep;63(9):1266-72
pubmed: 16831958
J Neurosurg. 2008 Sep;109(3):405-9
pubmed: 18759568
BMC Neurol. 2021 Mar 17;21(1):122
pubmed: 33731033
Mov Disord. 1994 Jul;9(4):441-6
pubmed: 7969212
Clin Neurol Neurosurg. 2011 Nov;113(9):808-9
pubmed: 21890261
Br J Psychiatry. 2013 Jul;203(1):51-7
pubmed: 23222039
Acta Neurochir (Wien). 2009 May;151(5):473-8; discussion 478
pubmed: 19322514
Turk Neurosurg. 2019;29(3):355-361
pubmed: 30984985
Schizophr Bull. 1999;25(4):731-40
pubmed: 10667743
Neurology. 2016 Feb 16;86(7):651-9
pubmed: 26791148
Life (Basel). 2021 May 24;11(6):
pubmed: 34074009
Mov Disord. 2006 Jun;21 Suppl 14:S284-9
pubmed: 16810675
J Neurosurg. 2015 Jan;122(1):191-4
pubmed: 25361490
Parkinsonism Relat Disord. 2015 Feb;21(2):116-9
pubmed: 25465373
Mov Disord. 2012 Sep 1;27(10):1205-15
pubmed: 22865512
J Neurosurg. 2002 Aug;97(2):461-6
pubmed: 12186477
Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S113-7
pubmed: 24262160
Neurology. 2009 Jul 7;73(1):53-8
pubmed: 19564584
Neuropsychiatr Dis Treat. 2021 Oct 14;17:3127-3134
pubmed: 34703232
J Manag Care Spec Pharm. 2019 Jul;25(7):810-816
pubmed: 31232207
Surg Neurol Int. 2020 Dec 16;11:444
pubmed: 33408929
Front Neuroanat. 2011 Apr 20;5:26
pubmed: 21541304
Tremor Other Hyperkinet Mov (N Y). 2013 Jul 12;3:
pubmed: 23858394
Biol Psychiatry. 1989 Mar 15;25(6):717-24
pubmed: 2466490
J Neurosurg. 2005 Apr;102(4):721-5
pubmed: 15871516
Biol Psychiatry. 1999 Dec 15;46(12):1672-81
pubmed: 10624549
J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1631-7
pubmed: 14638880
Curr Opin Psychiatry. 2012 Sep;25(5):381-90
pubmed: 22842659
J Clin Neurosci. 2014 Mar;21(3):515-7
pubmed: 23790619
J Neurol. 2022 Jul;269(7):3563-3568
pubmed: 35083518
Int Rev Neurobiol. 2011;98:289-96
pubmed: 21907092
Front Psychiatry. 2016 Dec 26;7:207
pubmed: 28082923